American Society of Hirudotherapy

Leech Histamine-like Vasodilator

Histamine-receptor-acting compound — contributes to local vasodilation at feeding site.

Preclinical / mechanistic: Evidence is preclinical (in vitro, animal models, or mechanism-of-action research). Clinical efficacy in humans has not been established.Last Updated: May 26, 2026 · ASH Editorial · based on the books
  • Hementerin80 kDa
  • Hementin80 kDa
  • Hementin-Like Protein (HLP-1)80 kDa
  • Leech Collagenase70 kDa
  • Haemadipsa yanyuanensis Progranulin (Hy-PGRN)70 kDa
  • Leech Apyrase67 kDa
  • Calin65 kDa
  • Hyaluronidase60 kDa
  • Antithrombin III binding protein58 kDa
  • Collagenolytic Fibrinolysin55 kDa
  • Leech Thrombospondin-Like Protein50 kDa
  • Leech Histamine-like Vasodilator0.2 kDa
Molecular weight (kilodaltons) of Leech Histamine-like Vasodilator (highlighted) alongside other characterized leech salivary compounds. Smaller proteins/peptides generally diffuse and act faster.

Mechanistic Evidence Box

Preclinical / mechanistic: Evidence is preclinical (in vitro, animal models, or mechanism-of-action research). Clinical efficacy in humans has not been established.
Page type
Compound profile
Evidence type
Preclinical / biochemical characterization
Evidence level
Mechanistic discussion
Drug vs leech
Leech-derived crude extract
Safety domains
Allergy / anaphylaxis

Clinical translation limit

Leech-derived histamine-like vasodilator activity is mechanistic only and does NOT establish any clinical therapeutic role. The histaminergic mechanism is relevant to understanding allergic/anaphylactic risk of leech application, not to claims of vasodilator efficacy.

Molecular Profile

Category
Vasodilator
Evidence tier
Preclinical
Molecular weight
200 Da
Source species
Hirudo medicinalis

Biological Targets

  • → H1 histamine receptor

External Resources

    Related Vasodilator Compounds

    This website provides educational information and does not constitute medical advice, diagnosis, or treatment recommendations. Medicinal leech therapy carries clinically meaningful risks and should be performed only by qualified clinicians under institutionally approved protocols. FDA 510(k) clearance for medicinal leeches is limited to specific indications; investigational and off-label discussions are labeled accordingly. For patient-specific guidance, consult a qualified healthcare provider.